Ultrasound may help monitor shoulder recovery in oral cancer survivors
NCT ID NCT07166575
First seen Jun 26, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study will use ultrasound to measure changes in a shoulder muscle (upper trapezius) in 10 oral cancer patients who had neck surgery and physical therapy. The goal is to see if ultrasound can track muscle recovery and relate it to how well patients can move their arm. It is an observational study, not testing a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could show that ultrasound is a useful tool for tracking muscle recovery in oral cancer patients after neck surgery.
- What could go wrong
- This is a very small, early observational study with only 10 participants, so results may not apply to all patients. It does not test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
School and Graduate Institute of Physical Therapy, Colledge of Medicine, National Taiwan University
RECRUITINGTaipei, 100, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a glowing drug light up head and neck tumors?
- Can a single tracer light up cancer's first stop? a trial puts a hybrid dye-and-radioactive marker to the test.
- New tracheostomy tube holder aims to cut infections and boost comfort
- HIV and cancer: study seeks to uncover hidden risk factors
- New drug combo targets HPV-Driven cancers in phase II trial
- Could an immunotherapy combo replace harsh chemo for head and neck cancer?